USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Arizeke Pharmaceuticals, Inc.
Address:
Arizeke Pharmaceuticals, Inc.
6828 Nancy Ridge Dr, Ste 400
San Diego, CA 92121 0228
Phone:
(858) 455-6907
URL:
N/A
EIN:
943274998
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $213,307.00 2
STTR Phase I $251,779.00 1

Award List:

Novel Aerosol Delivery System for Proteins

Award Year / Program / Phase:
2003 / SBIR / Phase I
Award Amount:
$107,000.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Because proteins and large macromolecular drugs do not normally cross epithelial barriers (i.e., intestine and lung), they are parenterally administered to patients. Injection is invasive and not well-accepted by patients or the medical community. Delivery of… More

Affinity Maturation and Transcytosis

Award Year / Program / Phase:
2003 / SBIR / Phase I
Award Amount:
$106,307.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): We have discovered a new method for administering proteins to the pulmonary system by a noninvasive technique using a receptor-mediated process. Because injection is invasive and not well accepted by patients, or the medical community, this method should be well… More

Quantitation Pulmonary Delivery of Therapeutic Protein

Award Year / Program / Phase:
2005 / STTR / Phase I
Award Amount:
$251,779.00
Agency:
HHS
Principal Investigator:
Research Institution:
HARVARD SCHOOL OF PUBLIC HEALTH
RI Contact:
N/A
Abstract:
DESCRIPTION (provided by applicant): Arizeke Pharmaceuticals, Inc. is focused on the pulmonary delivery of protein therapeutics (including antibodies) to treat pulmonary disease. Arizeke's technology provides a unique ability to deliver large therapeutic proteins into the lung parenchyma and… More